Journals / Abant Tıp Dergisi / 2015 / Cilt: 4 - Sayı: 4

Vitamin D and Cardiovascular Disease

Vitamin D ve Kardiyovasküler Hastalık

Pages
428–435
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In recent studies, it has been concluded that low VD levels are associated with cardiovascular risk factors age, obesity, diabetes mellitus, metabolic syndrome, chronic kidney disease .

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin D VD deficiency is a common health problem both in Turkey and worldwide.
📊
Key Findings & Data:Furthermore, there are studies showing the correlation between VD deficiency, and increase in carotid intima-media thickness and subclinical cardiovascular diseases such as endothelial dysfunction and coronary artery calcification and increase in total mortality.
💡
Conclusion & Impact:In recent studies, it has been concluded that low VD levels are associated with cardiovascular risk factors age, obesity, diabetes mellitus, metabolic syndrome, chronic kidney disease .
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vitamin D · kardiyovasküler hastalıklar · kardiyovasküler risk faktörleri

Abstract

Vitamin D VD deficiency is a common health problem both in Turkey and worldwide. Today, it is known that vitamin D deficiency plays a role in the occurrence of autoimmune diseases, inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes, cancer, psoriasis and cardiovascular diseases. In recent studies, it has been concluded that low VD levels are associated with cardiovascular risk factors age, obesity, diabetes mellitus, metabolic syndrome, chronic kidney disease . Furthermore, there are studies showing the correlation between VD deficiency, and increase in carotid intima-media thickness and subclinical cardiovascular diseases such as endothelial dysfunction and coronary artery calcification and increase in total mortality. We summarize the most recent studies evaluating the relationship between vitamin D and the presence of cardiovascular risk factors, including hypertension, obesity, type 2 diabetes mellitus, chronic kidney disease, dyslipidemia and endothelial dysfunction.

Özet

Vitamin D VD eksikliği dünyada ve Türkiye’de yaygın bir sağlık sorunudur. Günümüzde otoimmün hastalıklar, inflamatuar barsak hastalığı, romatoid artrit, multipl skleroz, diyabet, kanser, psoriasis ve kardiyovasküler hastalıkların oluşmasında D vitamini eksikliğinin rolü olduğu bilinmektedir. Son zamanlarda yapılan çalışmalarda düşük VD düzeylerinin kardiovasküler risk faktörleri yaş, obezite, diabetes mellitus, metabolik sendrom, kronik böbrek hastalığı ile ilişkili olduğu sonucuna varılmıştır. Dahası VD eksikliğinin karotis intima media kalınlığındaki artış, endotelyal disfonksiyonu ve koroner arter kalsifikasyonu gibi subklinik kardiyovasküler hastalıklar ve total mortalitedeki artış ile ilişkisini gösteren çalışmalar da vardır. Bu derlemede son çalışmalarda vitamin D ile hipertansiyon, obezite, tip 2 diyabet, kronik böbrek hastalığı, dislipidemi, ve endotelyal disfonksiyon gibi kardiyovasküler risk faktörleri arasındaki ilişkiyi özetledik.

🔖

Cite This Article

UÇAN, B., DELİBAŞI, T. (2022). Vitamin D and Cardiovascular Disease. Abant Tıp Dergisi, Cilt: 4 - Sayı: 4, 428–435. https://ajindex.com/articles/426953

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 2005; 98: 1024- 7
  2. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73-8
  3. TEMD Metabolik kemik hastalıkları kılavuzu. 2012 4. Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultraviolet radiation. Int. J. Epidemiol. 1981, 10, 337– 341
  4. Burgaz A, Orsini N, Larsson S. Et al. Blood 25- hydroxyvitamin D concentration and hypertension: A meta-analysis. J. Hypertens. 2011, 29, 636–645
  5. Wang L,Song Y, Manson J.E et al. Circulating 25- hydroxy-vitamin D and risk of cardiovascular disease: A metaanalysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 2012, 5, 819–829
  6. Green JJ, Robinson DA, Wilson GE et al. Calcitriol modulation of cardiac contractile performance viaprotein kinase C. J Mol Cell Cardiol 2006;41:350- 359
  7. Nibbelink KA, Tishkoff DX, Hershey SD et al. 1,25(OH)2Vitamin D3 actions on cell proliferation, size, gene expression, and receptor localisation, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007;103:533-537
  8. O’Connell TD, Berry JE, Jarvis AK et al. 1,25-dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997;272:H1751- H1758 10. Pilz S, Tomaschitz A, Drechsler C et al. Vitamin D deficiency and heart disease. Kidney Interna-tional Supplements 2011;1:111-115
  9. De Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for re- duction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010;376:1543- 1551
  10. Pittas AG, Chung M, Trikalinos T et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-314
  11. Wang TJ, Pencina MJ, Booth SL et al. Vitamin D defi- ciency and risk of cardiovascular disease. Circulation 2008;117:503-511
  12. Giovannucci E, Liu Y, Hollis BW et al. 25OHD and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174-1180
  13. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25OHD and 1,25 D with all cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-1349
  14. Forman J.P, Williams J.S, Fisher N.D.L. Plasma 25-hydroxyvitamin D and regulation of the reninangiotensin system in humans. Hy